United States· US:64980-514_ce38c2fa-e404-40e3-b684-8c31a58245be

TIMOLOL MALEATE

A timolol product containing timolol maleate, registered in United States by Rising Pharma Holdings, Inc.. The same ATC class is registered in 14 of our 19 countries.

ATC S01ED01

Checked against FDA National Drug Code directory (United States) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about timolol maleateAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Timolol is registered in 14 of 19 countries.

Countries holding a registration under ATC S01ED01 (timolol), each read from that country’s own register.

This record: United States, from FDA National Drug Code directory (United States)
9 of them publish a price we can compare per daily dose

Search timolol products by name

Timolol · ATC S01ED01

14 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of timolol costs, country by country.

Normalised to the WHO defined daily dose (0.2 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Timolol · price per daily dose (0.2 g)

USD · FX 28 Sept 2026

IT Italy$2.87

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)

Active substance: TIMOLOL MALEATE
Manufacturer: Rising Pharma Holdings, Inc.
Country: United States (US)
ATC code: S01ED01
ATC class: Timolol
Defined daily dose: 0.2 g, AS
Reimbursed: Not published by this register
Source register: FDA National Drug Code directory (United States)
Last checked: September 27, 2026

Packs & prices · 3

ndc11
64980-514-01
ndc11
64980-514-05
ndc11
64980-514-15

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

144 interactions on record for timolol.

Graded by severity as the source publishes them — 28 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check timolol against other medicines How interaction checks work

Timolol · interactions on record

144 records

28 severe
114 moderate
2 minor

Most severe, free to view

EpinephrineB02BC09severe
EpinephrineC01CA24severe
OrciprenalinC01CA29severe
TheophyllinC01EB28severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Timolol in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All timolol products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Timoftal, Timolol Micro Labs
Belgium · Geltim, Timabak
Bulgaria · Гелтим, Кузимолол
Cyprus · Lithimole
Czechia · Oftan, Timo-Comod
Germany · Dispatim, Gelisia
Denmark · Eyopto, Optimol
Estonia · Timosan
Spain · Cusimolol, Gelisia
Finland · Oftan Timolol, Timosan
France · Geltim Lp, Genoptol
United Kingdom (Northern Ireland) · Eysano, Timolol Blumont Pharma
Greece · Geltim, Lithimole
Croatia · Timalen
Hungary · Cusimolol
Ireland · Timofluid, Timolol Brown & Burk Ir
Iceland · Timosan Depot
Italy · Blocadren, Cusimolol
Lithuania · Oftan, Timosan
Luxembourg · Dispatim, Geltim
Latvia · Oftan Timolol, Timosan
Malta · Lithimole
Netherlands · Gelisia, Timo-Comod
Norway · Oftan, Timosan
Poland · Cusimolol, Timo-Comod 0,5 %
Portugal · Dibetop, Timabak
Romania · Gelisia, Geltim
Sweden · Optimol, Timosan
Slovenia · Timalen, Timoptic -Xe
Slovakia · Unitimolol

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/f2eb1128-4b9f-4bd1-8cd8-bb2f3c182b84
GET /v1/drugs/f2eb1128-4b9f-4bd1-8cd8-bb2f3c182b84?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "OPHTHALMIC",
  "source": "ndc",
  "strength": "5",
  "substance": "TIMOLOL MALEATE",
  "productndc": "64980-514",
  "dosage_form": "SOLUTION/ DROPS",
  "dea_schedule": null,
  "strength_unit": "mg/mL",
  "application_number": "ANDA077259",
  "marketing_category": "ANDA"
}

API reference MCP server Plans

See everything about timolol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console